Point72 Asset Management’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
Point72 Asset Management's MXCT Position: Q1 2026 in Review
Point72 Asset Management sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 106,151 shares — an estimated $165K sold.
Point72 Asset Management first reported a position in MXCT in Q3 2022 and held it in 7 quarters. The position peaked at $2.3M in Q4 2022. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- Point72 Asset Management reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
- Point72 Asset Management sold 106,151 MaxCyte shares in Q1 2026, an estimated $165K.
- Point72 Asset Management first reported a position in MaxCyte in Q3 2022 and held it in 7 quarters.
- Point72 Asset Management's MaxCyte position peaked at $2.3M in Q4 2022.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.